An Important Sequel, not the Usual Kind, in a Hot Genomics ETF

The ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) is one of the best-performing healthcare ETFs of any stripe over the past several years for a simple reason: the ability of the fund’s managers to identify companies that are breaking new ground in the rapidly evolving genomics arena....